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Arsenic is a well-established human toxin. Over 200 million people worldwide are exposed 
to arsenic, mainly through drinking water. Recently, several epidemiological studies have 
reported that even low concentrations of arsenic impair neurological functions across a broad age 
range in human [1]. However, the cellular and molecular mechanisms of arsenic’s effect on the 
central nervous system (CNS) are not well understood. The blood-brain barrier (BBB) is a 
complex multicellular structure separating the CNS from the systemic circulation and protects 
the neural tissue from toxins and pathogens. Alterations in the   BBB are an important 
component of pathology in many neurological disorders [2]. Therefore, arsenic may have a toxic 
impact on the BBB and thus affect the function of CNS.  Since brain endothelial cells (BECs) are 
the major component of the BBB and play important roles in maintaining the functional integrity 
of brain tissue under toxic exposure, we focused on arsenic-induced alterations in BECs in our 
study. Previously, our laboratory has reported that reactive oxygen species (ROS) play an 
important role in an arsenic-induced increase in brain endothelial cell permeability[3]. However, 
the underlying mechanism of arsenic-induced ROS generation in endothelial cells and how ROS 
regulate endothelial cell functions are unclear. Mitochondria are considered as the major source 
of ROS generation in mammalian cells and arsenic-induced mitochondrial dysfunction has been 
reported in many studies, which suggest that it may be associated with arsenic-induced oxidative 
stress in endothelial cells (ECs). In addition, autophagy, which is regulated by oxidative stress, 
plays an important role to control endothelial permeability and maintain redox balance in ECs 




Here, we studied mitochondrial ROS generation and the role of autophagy in arsenic-
induced toxicity in rat brain endothelial (RBE4) cell line. Our results demonstrate that 
arsenite increased mitochondrial ROS generation and MnSOD expression and decreased 
mitochondrial bioenergetics (mtBE) in RBE4 cells. In addition, immunoblot analysis of LC-
3(Microtubule-associated protein light chain 3) revealed that arsenite induced autophagy in 
RBE4 cells as observed by the increased expression of LC3-II and the ratio of LC3-II/LC3-
I, which were used as autophagy markers in our study.  Furthermore, the antioxidants N-
acetylcysteine (NAC) and tempol decreased arsenic-induced mitochondrial ROS generation 
and autophagy. However, only NAC rescued arsenic decreased mtBE and increased 
monolayer permeability in RBE4 cells. Taken together, our study supported that 
mitochondrial oxidative stress and ROS-induced autophagy were involved in arsenic 
toxicity in RBE4 cells. These findings have given us a new insight into the mechanism 
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Chapter 1 Introduction 
1.1 Introduction of Arsenic 
1.1.1 Arsenic Exposure is a Worldwide Problem                                                                                                                                                                                                  
The metalloid arsenic (As) is a natural component of the earth’s crust and is widely 
distributed throughout the environment. Arsenic is found in combination with either 
inorganic or organic substances to form many different compounds. Inorganic arsenic 
compounds are found in soils, sediments, and groundwater. These compounds occur 
naturally or as a result of mining, ore smelting, and industrial use of arsenic. Organic 
arsenic compounds are found mainly in fish and shellfish which are not known to be toxic 
to humans. In contrast, inorganic arsenic exposure has been implicated in a variety of health 
hazards [5]. Acute effects of arsenic range from gastrointestinal distress to death. 
Depending on its concentration, chronic arsenic exposure can cause cancer, skin lesions, 
cardiovascular diseases, and neurological impairment [6]. Arsenic holds the highest ranking 
on the current U.S. Agency for Toxic Substances and Disease Registry (ATSDR) 2017 
substance priority list [7]. 
As mentioned, arsenic is ubiquitous, and humans can be exposed to arsenic via 
contaminated drinking water, cigarettes, foods, industry, occupational environment, as well 
as air [8]. Among the various routes of arsenic exposure, arsenic contaminated drinking 
water is the largest source of arsenic poisoning worldwide [9]. Inorganic arsenic is naturally 
present at high levels in the groundwater of several countries, including Argentina, 




recognized that at least 140 million people in 50 countries have been drinking water 
containing arsenic at levels above the World Health Organization (WHO) provisional 
guideline value of 10 μg/L [10]. However, the symptoms and signs that are caused by long-
term elevated exposure to inorganic arsenic differ between individuals, population groups 
and geographical areas. As a result, there is no reliable estimate of the magnitude of the 
arsenic problem worldwide. Therefore, more research needs to be done to better understand 
arsenic toxicity. 
1.1.2 Arsenic Neurotoxicity 
Although the systemic and carcinogenic toxicity of arsenic has been studied in detail, 
its neurocognitive consequences have not been extensively explored. Recent studies have 
shown that even at low concentrations, arsenic can impair neurological function [11]. 
Epidemiological evidence has reported arsenic neurotoxicity in children and adults, with 
emphasis on cognitive dysfunction, including learning and memory deficits and mood 
disorders, as well as increased Alzheimer’s-associated pathologies (Table 1.1.2) [11]. The 
neurotoxic effects of arsenic have been reported not only in humans but also in many 
animal models. Arsenic exposure was link to impairments in learning and spatial memory in 
rodents as determined by poorer performance on hidden platform acquisition tests, novel 
object exploration as well as the Morris water maze test [1, 12, 13] . In addition, animal 
studies have demonstrated that prenatal and early postnatal arsenic exposure reduced brain 
weight, the numbers of glia and neurons as well as altering neurotransmitter systems [1]. 
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1.2 Brain endothelial cell 
The BBB is a highly specialized structural and biochemical barrier that regulates the 
entry of blood-borne molecules into the brain and preserves ionic homeostasis within the 
brain microenvironment [20].  As the  BBB plays an important role in CNS function, its 
dysfunction has been observed in various brain diseases including stroke, traumatic brain 
injury (TBI), neoplasia, multiple sclerosis, epilepsy, Alzheimer’s disease, and vascular 
cognitive impairment [21].  
Several animal studies have suggested that arsenic may cross the BBB and directly 
affect the CNS [1]. Arsenic may also have a toxic impact on the BBB itself and thus affect 
the function of CNS as it has been well documented that arsenic has a profound effect on 
the systemic vasculature. Recently, studies on the effects of mixed metals on the BBB 
showed that various metals, including arsenic, disrupted the integrity of the BBB likely via 
negative effects on astrocytes, leading to increased permeability of the BBB to toxicants and 
CNS neurotoxicity [22].  
The BECs are the major component of BBB and form the major interface between the 
blood and the CNS [18]. The BECs have unique properties compared with endothelial cells 
in other tissues that allow them to tightly regulate the movement of ions, molecules, and 
cells between the blood and the brain. On one hand, BECs are held together by tight 
junctions (TJs) and adherent junctions (AJs). TJ components such as claudins, occludin, and 
junctional adhesion molecules interact with the actin cytoskeleton by scaffolding proteins 




paracellular permeability. AJ proteins, including VE-cadherin, mediate cell to cell contact 
that supports the barrier properties and regulates TJ expression in BECs [23]. On the other 
hand, BECs undergo extremely low rates of transcytosis as compared with peripheral 
endothelial cells, which greatly restricts the vesicle-mediated transcellular movement of 
solutes. Taken together, this tight paracellular and transcellular barrier creates distinct 
lumenal and ablumenal membrane compartments that tightly regulate  molecular movement 
between the blood and the brain [24]. Since BECs play important roles in maintaining the 
functional integrity of brain tissue under toxic exposure, we used cerebral endothelial cells 
in our study to explore arsenic toxicity. 
1.3 Arsenic-induced vascular dysfunction 
Despite limited studies of arsenic’s effects on BECs, its effects on endothelial cells 
from other tissues and organs have been reported. ‘Blackfoot Disease’ in Taiwan is one of 
the most interesting and unique clinical complications of human arsenic exposure. This 
disease is characterized by peripheral vasculature collapse followed by gangrenous tissue 
death of the extremities [25-27]. In addition, epidemiological studies have also indicated 
that incidences of cardiovascular diseases, including high blood pressure, arteriosclerosis, 
myocardial infarction, stroke and diabetes, were significantly increased in arsenic-exposed 
populations [28]. All these vascular injuries suggest a strong correlation between 
endothelial cell dysfunction and arsenic exposure. Therefore, our current study proposes 
that arsenic may have a direct effect on brain endothelial cells. Since increased vascular 




pathological sign of early vascular injury, our study focused on arsenic’s effects on brain 
endothelial cell permeability. 
1.4 Oxidative Stress 
1.4.1 ROS and RNS 
Several studies of isolated vascular cells and tissues have provided clear evidence that 
arsenic stimulates the production of ROS and promotes oxidative stress in ECs [29]. 
Therefore, disruption of redox signaling is one of the potential mechanisms widely accepted 
in arsenic-induced toxicity in ECs [30, 31]. 
Oxidative stress results from an imbalance between the generation and detoxification 
of ROS. ROS is an umbrella term that generally refers to a family of oxidizing species 
derived from one- or two-electron reduction of molecular oxygen, including superoxide 
anion (O2•–.), hydroxyl radical (•OH), and hydrogen peroxide (H2O2)[32]. Added to this list 
are other species such as peroxynitrite (ONOO−) formed from O2•– and nitric oxide (•NO), 
nitrogen dioxide radical (•NO2) formed from ONOO−or myeloperoxidase (MPO)/ H2O2-
dependent oxidation of nitrite anion (NO2–),  which are also referred to as reactive nitrogen 
species (RNS) [33]. ROS are continuously generated by the mitochondrial electron-
transport chain. In healthy cells, ROS levels are under homeostatic control by the 
endogenous antioxidant defense system that includes biological antioxidants such as 
glutathione (GSH), vitamin E, and vitamin C and antioxidant enzymes including catalase, 
superoxide dismutase (SOD), glutathione peroxidase (GPx), and heme-oxygenase I (HO-1). 




capacity. In addition, RNS, include •NO, which is relatively unreactive, and its derivative, 
ONOO−, which is a powerful oxidant, can act together with ROS to damage many 
biological molecules [34]. Therefore, these two species are often collectively referred to as 
ROS/RNS. 
1.4.2 Oxidative Stress Affects BBB 
Oxidative stress contributes to brain injury by reacting with proteins, lipids, and 
nucleic acids, as well as by activating a number of redox-sensitive signaling pathways [35] . 
Emerging evidence has shown that production of ROS can affect BBB permeability by a 
variety of mechanisms, including modulation of endothelial cell TJ and AJ proteins, such as 
ZO-1 and VE-cadherin [36]. 
BECs are equipped with a defense system against oxidative stress that includes  
increased levels of GSH, GPx(Glutathione peroxidase), SOD and catalase compared to the 
rest of the brain [37]. Among them, GSH in particular has been shown to play an important 
role in maintenance of BBB integrity. In addition, manganese-containing SOD (MnSOD/ 
SOD2) is found in the mitochondrial matrix while copper- and zinc-containing SOD 
(CuZnSOD) is found mostly in the cell cytosol. These enzymes aid in the conversion of O2•− 
to H2O2, which is also a ROS, but it is removed by catalase (and other enzymes) in BECs. 
In addition, ONOO−, which can contribute to BBB breakdown, is also reduced through this 
conversion [38]. Without this system, ONOO−  can rapidly form due to high concentrations 
of NO, particularly in the endothelial cells [39]. 




Mitochondria are considered one of the main sources of ROS production. It is 
estimated that approximately 0.2–2% of the oxygen taken up by a cell is converted by 
mitochondria to ROS, mainly through the production of O2•− [40]. The sites of O2•− 
production along the mitochondrial respiratory chain have been the subject of many studies. 
The two major sites of O2•− production are complex I (NADH–coenzyme Q reductase) and 
complex III (ubiquinone–cytochrome c oxidoreductase). Mitochondria produce superoxide 
anion predominantly from complex I when the matrix NADH/NAD+ ratio is high. This 
leads to a reduced FMN site on complex I and reverse electron transport. In addition, 
complex III has also been regarded as a source of O2− within mitochondria for a long time. 
When supplied with CoQH2 and when the Qi site is inhibited by antimycin, complex III 
produces substantial amounts of O2•− from the reaction of O2 with a ubisemiquinone bound 
to the Qo site [18]. However, ROS are also produced to a lesser extent outside of the 
mitochondrion [41]. 
1.4.4 ROS and Mitochondrial Dysfunction 
Mitochondria are the most important target to study oxidative stress because they are 
not only the major source of ROS generation, but also sensitive targets of free oxygen 
radicals. Oxidative stress can induce mitochondrial DNA mutations, damage the 
mitochondrial respiratory chain, alter membrane permeability, influent Ca2+ homeostasis 
and affect mitochondrial defense systems [42]. 
As mentioned before, complexes I and III are thought to be major sites for the 




attack occurs directly at these complexes in the mitochondrial respiratory chain. In addition, 
as mentioned above, the O2•− generated in mitochondria is converted to H2O2 by 
spontaneous dismutation or by SOD and converted to water by GPx or catalase. If this does 
not occur, H2O2 can undergo Fenton's reaction in the presence of divalent cations such as 
iron to produce •OH, which can be even more harmful to the mitochondrial biomolecules. 
The highly reactive •OH can damage macromolecules within mitochondria, including lipids, 
proteins and DNA. The mitochondrial production of O2•− might be also modulated by NO, 
which can be converted to various reactive nitrogen species such as NO− or the toxic 
ONOO− [43, 44]. 
Overall, ROS can damage mitochondrial NADH dehydrogenase, cytochrome c 
oxidase, and ATP synthase, leading to defective complex I and/or III function and further 
result in shutdown of mitochondrial energy production.  
1.4.5 Oxidative Stress Measurement 
Detection of Mitochondrial O2•− Using MitoSOX 
In 2003, Kalyanaraman and colleagues created a superoxide-specific product from the 
reaction of DHE with O2•− [45]. Following this original report, DHE has been modified to 
allow detection of O2•− in the mitochondria by addition of a triphenylphosphonium group, 
which promotes its accumulation in the mitochondria. This modified DHE analog is 
referred to as MitoSOX and has become commonly used for detection of mitochondrial 
O2•−. Briefly, MitoSOX reacts with mitochondrial O2•− to form 2-hydroxy-mito-ethidium (2-




be made using the peak excitation wavelength of 510 nm with emission detection at 590 nm 
[46, 47]. In terms of its specificity for mitochondrial-derived O2•−, previous studies have 
shown that blockade of mitochondrial complex 3 with antimycin A increases the conversion 
of MitoSOX to 2-OH-Mito-E but has no effect on conversion of DHE to 2-OH-E+. In 
contrast, stimulation of cytoplasmic O2− using phorbol-12-myristate-13-acetate (PMA) 
increases 2-OH-E+ formation from DHE but does not increase formation 2-OH-Mito-E+ 
from MitoSOX [48].  
 
Figure 1.1 Mitochondrion-targeted accumulation of MitoSOX and detection of 
mitochondrial O2•−[46] 
 
ROS Detection Using EPR Spectroscopy 
Direct detection of ROS and RNS is very difficult or impossible in solution at room 
temperature due to their very short half-life. Electron paramagnetic resonance (EPR) 




EPR is a principally non-destructive, spectroscopic technique used to detect and identify 
paramagnetic species (species with unpaired electron(s)). The phenomenon of EPR is based 
on an intrinsic magnetic moment of the electron that arises from its spin. In most systems, 
electrons occur in pairs, such that the net magnetic moment is zero. However, if an unpaired 
electron is present, its magnetic moment can suitably interact with a magnetic field. The 
electron processes about the field axis with its magnetic moment either parallel or 
antiparallel to the field vector. This defines two energy levels [49]. 
 As mentioned above, ROS half-life is too short compared to the EPR time scale so 
that they result in being EPR-invisible. However, they  become EPR detectable once 
“trapped” and transformed in a more stable radical species. [46]. Among spin trapping or 
spin probe molecules, suitable for biological utilization, the CMH (1-hydroxy-3-
methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine) probe was adopted [50]. The superoxide 
free radical is known to react with the CMH probe, which is EPR silent, and converts it to a 
nitroxide radical (paramagnetic), which is EPR active and exhibits a characteristic triplet 
EPR signal. The specificity of CMH for superoxide free radicals has been well established. 
Thus, the appearance of a triplet EPR signal is indicative of superoxide and the peak height 
is a measure of the amount of superoxide accumulation in cultured cells and tissue samples 





Figure 1.2 Spin probe CMH form stable adducts with radicals[52] 
 
1.4.6 Antioxidant therapy 
Even though antioxidant agents have not been used clinically to treat chronic arsenic 
poisoning, numerous experimental studies have shown the beneficial effects of antioxidant 
agents on in-vivo and in-vitro models exposed to arsenic treatment.  
N-acetyl-cystine 
N-acetyl-cystine (NAC) is an acetylated variant of the amino acid L-cysteine, which is 
able to increase cell protection to oxidative stress. NAC works as an effective scavenger of 
free radicals via interacting with ROS such as .OH and H2O2. In addition, it predominately 
maintains the cellular GSH status and minimizes the oxidative effects of ROS through 
correcting or preventing GSH depletion [53]. Therefore, NAC has been used in the clinic to 
treat a variety of conditions including drug toxicity (acetaminophen toxicity) , human 




(COPD) and diabetes. [54]. Interestingly, NAC was recently reported to reduce brain 
dysfunctions and neuropathies which further became a promising agent to treat vascular and 
nonvascular neurological disorders, via modulating glutamatergic, neurotrophic and 
inflammatory signaling pathways [55]. 
Tempol 
Tempol (4-hydroxy-Tempo), is a redox-cycling (catalytic), metal-independent, and 
membrane-permeable antioxidant. It is a particularly attractive molecule because it 
promotes metabolism of O2•− at rates that are similar to SOD and is therefore considered a 
SOD mimetic. However, a recent report showed that tempol may facilitate metabolism of a 
wide range of ROS and RNS species, including OH−, and exhibits catalase activity that 
further prevents generation of OH− and H2O2 by Fenton reactions. Tempol also improves 
NO bioavailability and catalytically removes the highly reactive ONOO− species that is 
produced by the reaction between O2− and NO [56, 57]. Accordingly, Tempol has been 
studied in several models of oxidative stress. Tempol has been found to protect many 
organs, including the brain and the heart, from ischemia/reperfusion injury and improved 
survival in different models of shock. It also reduces brain or spinal cord damage after 
ischemia or trauma, among several other effects [58]. However, some studies have shown 
that tempol may have some toxic effects including impairing mitochondrial function in 
several cell lines [59, 60]. 
1.5 Autophagy 




Autophagy is a catabolic process that degrades intracellular components through the 
lysosomal machinery. Three types of autophagy have been identified: 1) chaperone-
mediated autophagy, which is a biochemical mechanism to deliver cytoplasmic proteins to 
lysosomes through the chaperone complex; 2) microautophagy, that directly uptakes 
cytoplasmic materials by lysosomes via a process similar to pinocytosis; and 3) 
macroautophagy, by which cytoplasmic organelles and proteins are delivered to lysosomes 
through the fusion of autophagosomes and lysosomes. Macroautophagy is the most studied 
type of autophagy and we focus on macroautophagy (here after referred to as autophagy) in 
our study [61]. 
The process of autophagy is initiated by the formation of a phagophore (or isolation 
membrane), which is likely derived from the lipid bilayer of the endoplasmic reticulum, 
Golgi apparatus, mitochondria or plasma membrane. The phagophore elongates and 
subsequently engulfs a portion of cytoplasm, thereby sequestering the cargo in a double 
membrane structure known as an autophagosome. The outer membrane of the 
autophagosome fuses with the lysosomal membrane to form an autolysosome, leading to the 
degradation of the autophagosomal inner membrane along with the sequestered materials by 
lysosomal acid proteases. The degradation products are then transported back into the 
cytoplasm to be recycled. Upon autophagy induction, the cytosolic LC3 (LC3-I) is 
conjugated to phosphatidylethanolamine (PE) to form lipidated LC3 (LC3-II). LC3-II binds 
to the expanding isolation membrane and remains bound to complete autophagosome. 
Therefore, LC3-II is widely used as a marker for autophagosomes [62] (Figure 1.3). One 




of autophagosomes, but most importantly, flux through the entire system, including the 
degradation upon fusion with lysosomes. Assays that determine autophagic flux are crucial 
for the assessment of the dynamic autophagy process and help to distinguish between the 
accumulation of autophagosomes due to induced autophagic activity versus accumulation 
due to inefficient lysosomal clearance.  
Currently, there is no single “gold standard” for determining autophagic activity that is 
applicable in every experimental context. There are four methods that are widely used to 
analyze autophagy, including LC3 turnover by immunoblotting, degradation of autophagic 
substrate p62 and tandem fluorescent-tagged LC3 assay to monitor autophagic flux. In 
addition, the fluorescence microscopy of LC3-positive vesicles is used to assess the static 
levels of autophagosomes. In most cases, it is highly recommended to combine multiple 
approaches to detect an autophagic response induced by a drug or treatment. 
To date, the most experimentally straightforward method to monitor autophagic 
activity is the detection of LC3 protein processing. The amount of autophagosomes detected 
at any specific time point is a function of the balance between the rate of their generation 
and the rate of degradation though fusion with lysosomes [63]. Thus, we detected LC3-II 
formation by immunoblotting to monitor autophagic activity in our study. Furthermore, we 
used NH4Cl, which can prevent lysosomal degradation of LC3-II by altering lysosomal pH 
to help us distinguish whether arsenic-induced-accumulation of autophagosomes are due to 





Figure 1.3 The process of autophagy. The autophagosome fuses with a lysosome to 
form an autolysosome, and then the cytoplasmic materials are degraded by the lysosome. 
The initiation step of autophagosome formation requires the ULK1-Atg13-FIP200 complex 
and Beclin1-class III PI3K complexes. Two conjugation systems, Atg12-Atg5-Atg16 and 
Atg8-PE, are essential for the elongation and enclosure step of the autophagosome 
formation. Lipid conjugation leads to the conversion of the soluble form of LC3-I to the 
autophagic vesicle-associated form LC3-II, which is commonly used as a marker of 
autophagy. mTOR plays a critical role in regulating autophagy. Figure adapted from Fig 1. 
in Ref[65]. 
1.5.2 Autophagy Inhibitors 
Since several studies have shown that autophagy is involved in many human diseases, 
various compounds or strategies have been utilized to induce or suppress autophagy both in 
vitro and in vivo. 
 Among them, 3-methyladenine (3-MA) is one of the most commonly used inhibitors in 




formation via the inhibition of class III PI3K.  In fact, PI3K plays an important role in many 
biological processes, including controlling the activation of mTOR, a key regulator of 
autophagy. In addition, many studies have revealed the protective effect of 3-MA. For 
instance, administration of 3-MA markedly reduced lung vascular leakage and tissue edema 
[67]. Moreover, 3-MA showed neuro-protective effects in seizure-induced brain injury [68]. 
Nevertheless, some nonspecific effects of 3-MA independent of autophagy inhibition have 
been reported, including inhibition of class I PI3K and mTOR, suppression of protein 
degradation, and cell migration and invasion [69].  
1.5.3 Autophagy and Mitochondrial Oxidative Stress 
It has been well known that the conditions which regulate the activity of the autophagic 
process are associated with cellular changes in the production of ROS/RNS. Not 
surprisingly, mitochondrial ROS production and oxidation of mitochondrial lipids have 
been shown to play a significant role in autophagy. It has been reported that rapamycin-
induced autophagy in yeast is accompanied by the production mitochondrial superoxide and 
this effect can be inhibited by  NAC [70]. In addition, starvation induced autophagy can be 
inhibited by overexpression of SOD2 and catalase, which reduced both O2•− and H2O2 levels 
[71]. 
In addition, autophagy also plays an important role in the regulation of mitochondrial 
function. It has been shown that mitochondria have an average half-life of 10–25 days in 
normal mammalian brains. However, during starvation, mitochondrial turnover can be 




mitochondria are typically programmed for removal by mitophagy and it has been shown 
previously that inhibition of mitophagy results in the accumulation of damaged 
mitochondria which further generate increased levels of reactive oxygen species. 
Recent studies have demonstrated that arsenic can induce mitochondrial oxidative 
stress and the presence of ROS can trigger autophagy in other systems. However, the exact 
mechanism of how arsenic alters autophagy signaling is not fully investigated, especially in 
BECs. 
1.5.4 Autophagy and Endothelial Permeability 
Autophagy is active in endothelial cells in vitro and in vivo, but its functional role is 
quite controversial. In human umbilical vein endothelial cells (HUVECs), autophagy is 
induced upon silencing of vascular endothelial growth factor (VEGF), and subsequently 
leads to cell death [73]. Conversely, autophagy promotes cell survival in response to 
hypoxia in bovine aortic ECs (BAECs) cultured under glucose-deprived conditions [74]. 
More importantly, autophagy has also been implicated in regulating endothelial cell 
monolayer permeability. Some reports consider autophagy as a self-protective mechanism 
to maintain the endothelial cell permeability. Inhibiting autophagy in endothelial cells, 
either pharmacologically or by silencing ATG5 with siRNA, increases cellular ROS 
production which may impair ECs permeability. Therefore, some researchers suggest that 
ECs require autophagy to control ROS levels to maintain their permeability [4]. However, it 
has also been reported that loss of mitochondrial membrane potential under stress 




with a PI3K inhibitor (3-MA), or autophagosomal-lysosomal fusion inhibitors (bafilomycin 
A1 and chloroquine) can rescue some inflammatory factor (rMIF) induced vascular leakage 
[76]. To sum up, these studies support the notion that autophagy is a self-destructive 
mechanism instead of a cell survival mechanism. 
1.6 Statement of Purpose 
Arsenic is ranked first among toxicants that cause a significant potential threat to 
human health based on known or suspected toxicity [9]. Recently, arsenic-induced 
neurotoxicity has been widely reported. Several epidemiological studies have shown that 
even low concentrations of arsenic impairs neurological functions across a broad age range 
in human, leading to learning or memory deficits in childhood, impairing cognitive ability 
in adults and increasing the risk of neurodegenerative diseases or mood disorders [30, 77]. 
However, the cellular and molecular mechanisms of arsenic’s effect on the CNS are not 
well understood. The BBB is a complex multicellular structure separating the CNS from the 
systemic circulation and its major functions include controlling molecular traffic, keeping 
out toxins, contributing to ion homeostasis and allowing immune responses, which suggest 
that  disruption of the BBB is an important part in cellular damage in neurological diseases 
[78, 79] [80].   
Therefore, we propose that arsenic may have a toxic impact on the BBB integrity and 
contribute to CNS dysfunction. Since BECs are the major units of the BBB, we focused on 




Previous studies have demonstrated that arsenic caused vascular dysfunction such as 
increased endothelial permeability and our laboratory has reported that ROS plays a 
significant role in arsenic-induced increase in brain endothelial cell permeability [3, 81, 82]. 
Mitochondria are considered as the major source of ROS generation in mammalian cells 
and it has been reported that mitochondria are a main target for arsenic toxicity [31]. 
Therefore, mitochondria may be the source of arsenic-induced ROS generation in ECs. In 
addition, autophagy, which is regulated by oxidative stress, plays an important role to 
control endothelial permeability and maintains redox balance in ECs and it may also be 
involved in arsenic toxicity in BECs [4]. Thus, we hypothesize that arsenic toxicity in BECs 
is mediated by mitochondrial oxidative stress and increased autophagyy. To test this 
hypothesis, we l studied the effect of sodium arsenite on RBE4 cells, which are commonly 
used to study BBB integrity and function. 
To study the arsenic toxicity on mitochondrial oxidative stress in RBE4 cells, we 
determined the cell oxygen consumption and mitochondrial superoxide production in RBE4 
cells after arsenite exposure for 24 hrs. Subsequently, we treated RBE4 cells with arsenite in 
the presence of antioxidant compounds to understand the relationship between arsenite 
induced mitochondrial oxidative stress and cellular dysfunction in RBE4 cells. 
To identify the role of autophagy in arsenic-induced toxicity in RBE4 cells, we first 
detected autophagic activity under arsenite exposure using the autophagosome marker 
LC3II. Next, we further detected the autophagic activity in RBE4 cell under arsenic 
exposure with or without antioxidant to understand the relationship between arsenic-




RBE4 cells with arenite in the presence of autophagy inhibitors to investigate the role of 
arsenic-induced autophagy in increased permeability and mitochondrial dysfunction. 
Taken together, we expect to reveal the potential mechanism of arsenic toxicity in 
brain endothelial cells, to understand the source of ROS production and the downstream 





Chapter 2 Materials and Methods  
2.1 Reagents 
Name Company Catalog Number 
Collagen I Corning 354236 
Sodium (meta)arsenite Sigma-Aldrich 71287 
N-Acetyl-L-cysteine Alfa Aesar A15409 
4-Hydroxy-TEMPO Sigma-Aldrich 176141 
Fluorescein 
isothiocyanate–dextran Sigma-Aldrich FD40S 
XF Assay Medium 
Modified DMEM Seahorse Bioscience 102365-100 





Rotenone Sigma-Aldrich R8875 
Antimycin A Sigma-Aldrich A8674 




CMH. hydrochloride Enzo Life Science ALX-430-117-M010 
Ammonium Chlorid Fisher A661-500 
MitoSOX Fisher M36008 





2.2.1 Cell Culture and Treatment 
Rat brain endothelial (RBE4) cells, provided as a gift by Dr. Michael Aschner from the 
Albert Einstein College of Medicine, were grown until confluent on T25 flasks coated with 
rat tail collagen I at 50 μg/ml (354236, Corning). RBE4 (passage 1–20) were cultured in 
growth media composed of 44% alpha-MEM: 44% Ham’s F-10 Nutrient (12571-063 and 
11550-043, respectively; Invitrogen) supplemented with 10% heat-inactivated fetal bovine 
serum, plus freshly prepared 1 ng/ml basic fibroblast growth factor (PHG0264, Invitrogen), 
300 μg/ml Geneticin (10131035, Invitrogen), penicillin/ streptomycin and maintained in a 
humidified 37 °C, 5% CO2 incubator. Media was replaced every 2 days. 48 hours after 
plating, cells were treated with sodium arsenite at various concentrations. 
1.3 mg of sodium arsenite was dissolved in 1 ml sterile water to prepare a stock 
solution of 10 mM and stored at -20°C up to 3 months. NAC was dissolved with PBS pH 
7.4 to prepare as a stock solution of 100 mM and stored at 4°C. 3-MA (macroautophagy 
inhibitor) was prepared in culture medium and NH4Cl (inhibitor of lysosomal function by 
increasing the intra-lysosomal pH) was dissolved in sterile water immediately before use. 
2.2.2 Paracellular Permeability Assay 
Paracellular permeability was detected as described previously [83]. Briefly, RBE4 
cells were seeded at an initial density of 2 × 105 cells/cm2 on the inner surface of 
polyethylene terephthalate (PET) cell culture inserts coated with 50 μg/ml of rat tail 




RBE4 media, respectively. Cells were allowed to grow for 2 days at 37 °C in 5% CO2  to 
confluency before arsenite treatment for 1, 3 or 6 days. Permeability of confluent 
monolayers was measured by adding FITC-labeled dextran (40kDa) to the upper chamber to 
a final concentration of 1 mg/mL. After incubation at 37°C, 5% CO2 for 3 hrs, 50 μl of 
medium from the outside of the insert was taken and diluted to 500 μl with PBS. 
Fluorescence intensity of FITC-dextran was measured at the excitation wavelength of 492 
nm and the emission wavelength of 520 nm by a fluorescent multi-mode microplate reader. 
2.2.3 Mitochondrial Bioenergetics (mtBE) Assessment  
RBE4 mtBE were analyzed using a Seahorse XF96 Analyzer. RBE4 cells were seeded 
in XF96-well plates (50,000 cells per well in 100 μl) and incubated overnight at 37°C, 5% 
CO2 overnight. RBE4 media (80 μl) with sodium arsenite was added to achieve a final 
concentration of arsenite at 0, 2,5 and 10 μM (n=8 wells). After 24 hrs, cells were washed 
twice with pre-warmed XF assay medium containing 5 mM glucose, 1mM sodium pyruvate 
and incubated at 37°C without CO2 at least 60 minutes prior to loading plate into the XF96 
instrument. The sensor cartridge was loaded with oligomycin (20 μg/ml, port B), carbonyl 
cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP, 2μM, port C) and rotenone plus 
antimycin-A (1 μM each, port D) to measure the bioenergetic profile. Once the sensor 
cartridge was equilibrated, the calibration plate was replaced with the cell plate then 
introduced into the Seahorse Analyzer using a 3-minute mix cycle to oxygenate the medium 
followed by a 4 min measurement of the Oxygen Consumption Rate (OCR)  




An EPR instrument (Bruker BioSpin) was adopted for determining superoxide levels 
in  RBE4 cells.  
The EPR samples were prepared 24 hrs after arsenite treatment. RBE4 cells from 3 
wells in 6-well plates were trypsinized and treated with 1 mM CMH for 3 hrs. The cells 
were washed with ice cold PBS and stored at -80 °C for further analysis [84]. 
Samples were assayed in 50 µL glass capillary tubes at room temperature using the 
Bruker e-scan EPR spectrometer. Spectrometer settings were as follows: sweep width, 100 
G; microwave frequency, 9.75 GHz; modulation amplitude, 1 G; conversion time,5.12 ms; 
time constant 5.12 ms; receiver gain, 2 × 102; number of scans, 30 [85]. Quantification of 
the EPR signal intensity was determined by comparing the intensity of the recorded middle-
derivative EPR peak of each sample. 
2.2.5 Evaluation of Mitochondrial Oxidative Stress  
RBE4 cells were seeded at a low density onto Lab-Tek eight-well chamber slides. 
After 24 hrs of arsenite exposure, mitochondrial ROS generation was determined using 
MitoSOX Redaccording to the manufacturer's instructions. Briefly, the cells were washed 
with PBS and incubated with fresh medium containing 2.5 μM MitoSOX for 20 min. The 
cells were loaded with 0.5 μg/mL Hoechst 33342 in HBSS for 5 min at 37 °C in the dark 
after washing 3 times with PBS. The excitation wavelength was 510 nm for MitoSOX and 
emission was measured at 580 nm. Images were taken using a Leica DMI4000 B 
microscope. Digital images from three wells were collected per experiment and corrected 




thresholding. The mean fluorescence intensity per image was calculated and averaged over 
the three images, using Image J software [86]. 
2.2.6 Immunoblotting 
After treatments, total cell lysates were prepared with RIPA buffer. Protein 
concentrations were measured with the BCA Protein Assay according to the manufacturer’s 
manual. Equal amounts (10-15 μg) of protein were separated by 12% sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis and were transferred to polyvinylidene fluoride 
membranes. Membranes were incubated overnight at 4 °C with a 1:2000 dilution of anti-
LC3B (ab43894) or 1:2000 dilution of anti-MnSOD (06984, Millipore). After additional 
incubation with a 1:3000 dilution of an anti-immunoglobin horseradish peroxidase-linked 
antibody (W4011, Promega) for 1 hour, the immune complexes were visualized using 
Supersignal™ chemiluminescent horseradish peroxidase substrate (32106, Thermo 
scientific). Densitometric analysis was performed using Image J analysis software (NIH). 
To normalize the protein levels, the intensity of band were first normalized to the mean 
intensity of the bands of control following by normalized to its beta-actin band. 
2.2.7 Statistical Analysis 
All data were pooled from at least three independent experiments. Student t-test was 
applied to determine the significance differences between two groups of samples. One-way 
ANOVA was used to determine overall significance differences followed by post hoc 
Tukey’s test for multiple comparisons using SAS. All data are presented as mean ± SEM. 




Chapter 3 Results 
3.1 Arsenite Induced Increased of Cell Monolayer permeability in RBE4 cells 
The effect of arsenite on RBE4 cell monolayer permeability was assessed by FITC-
dextran leakage assay. This method has been widely used to detect cell monolayer 
permeability in vitro. A confluent monolayer of RBE4 cells was grown on inserts was 
treated with 0-10 µM arsenite up to 6 days. The permeability of the monolayer was 
determined by measuring the content of FITC-dextran leaked from the insert to the medium 
of the plate well. For easy comparison, the percentage change of permeability was 
calculated from this basal value. As Figure 3.1 shows, the cell monolayer permeability 
increased with arsenite concentration and exposure time. At the concentration of 5 µM, 
arsenite caused a significant increase in permeability after 6 days of treatment. However, 
cells treated with 10 µM arsenite had a significantly permeability increase at both day 3 and 






Figure 3.1 Arsenite increased RBE4 monolayer permeability. RBE4 cells in culture 
inserts were grown to monolayer and exposed to 0-10 μM arsenite for 1, 3, and 6 days. 
Fluorescence of FITC-dextran leaked from insert to plate well was assessed to determine 
the permeability. Data were normalized to the value of control (0 μM arsenite) of the same 
treatment day. A) RBE4 cells in culture inserts were grown to monolayer and exposed to 0-
10 μM arsenite for 1 day. One-way ANOVA shows no significant main effect of 1 day As 
treatment on FITC dextran passage: F (3, 32) = 2.84, P=0.053 B) RBE4 cells in culture 
inserts were grown to monolayer and exposed to 0-10 μM arsenite for 3 days. One-way 
ANOVA shows significant main effect of 3 day As treatment on FITC dextran passage: F (3, 
32) = 4.29, P=0.011. Post hoc by Tukey’s multiple comparisons test shows FITC dextran 
passage was increased significantly in the group treated with 10 µM As compared to control 
group(*p<0.05). C) RBE4 cells in culture inserts were grown to monolayer and exposed to 




treatment on FITC dextran passage: F (3, 32) = 8.92, P= 0.00019. Post hoc by Tukey’s 
multiple comparisons test shows FITC-dextran passage was increased significantly in the 
group treated with 5 µM and10 µM As compared to control group (*p<0.05). Results were 





3.2 Arsenite Increased ROS Production in RBE4 Cells 
It is known that arsenic induces ROS generation in many types of endothelial cells 
[87]. To determine whether ROS is involved in arsenite-induced permeability in RBE4 
cells, we evaluated the levels of ROS in RBE4 cells after 24 hrs of arsenite treatment (0-10 
µM). Oxygen-derived free radical production from RBE4 cells was analyzed by EPR with 
the use of the  spin probe, CMH. As noted in Figure 3.2, 5 and 10 µM arsenite treatment 
resulted in a significant increase in intensity of the EPR signal, indicating a significantly 








Figure 3.2 Arsenite Increased ROS Production in RBE4 Cells. A) EPR spectral 
profile of ROS production from RBE4 cells after 24 hrs various concentrations (0-10 µM) 
of sodium arsenite treatment. To detect levels of ROS, cell pellets were incubated with the 
spin probe CMH (1mM) for 3 hrs following a wash with iced cold PBS. B) Quantification 
of the EPR signal intensity was determined by comparing the intensity of the recorded 
middle-derivative EPR peak of each sample. Data were normalized to the value of control 
(0 μM arsenite) of each experiment; One-way ANOVA shows a significant main effect of 
As treatment on EPR intensity: F (3, 8) = 9.72, P= 0.00013. Post hoc by Tukey’s multiple 
comparisons test shows that EPR intensity was increased significantly in the group treated 
with 5 µM As and  10 µM As compared to control group (*p<0.05). ). Results were 




3.3 Arsenite Induced RBE4 mtBE Loss in RBE4 Cells 
Our present study provided evidence that arsenic induces oxidative stress in RBE4 
cells. In addition, mitochondria are well known to play important roles in ROS generation 
and arsenic-induced mitochondrial dysfunction has been observed in many studies [31]. 
Based on these observations, we hypothesized that mitochondrial dysfunction following 
exposure to arsenic may be associated with the generation of ROS in RBE4 cells.  
To assess this, we evaluated mitochondrial function in RBE4 cells in response to 
various concentrations of sodium arsenite. Mitochondrial function was evaluated by the 
Seahorse extracellular flux analyzer, which allows for real-time measurements of oxygen 
consumption and provides an overall assessment of cellular mtBE.  
 We found that arsenic has no effect on mitochondrial basal respiration and ATP-
linked respiration in RBE4 cells. However, arsenic treatment decreased the oxygen 
consumption induced by FCCP, which is referred to as the maximal respiratory capacity 
(MRC), in a dose dependent manner in RBE4 cells (Figure 3.3). MRC reflects the rate of 
maximal electron transport and substrate oxidation achievable in the absence of limits 
imposed by the inner mitochondrial membrane proton gradient. Therefore, the decrease in 
MRC after arsenite treatment suggests that mitochondrial electron transport chains in the 









Figure 3.3 Arsenite decreased mtBE in RBE4 in a dose dependent manner. Oxygen 
consumption in RBE4 cells after 24 hrs exposure to sodium arsenite. OCR was manipulated with 
injections of oligomycin (20 μg/ml), FCCP (2 μM), and rotenone plus antimycin-A (1 μM). A) 
Representative bioenergetics profile of RBE4 cells treated with 2, 5, and 10 µM of sodium 
arsenite for 24 hrs. B) Quantification of MRC. MRC was achieved by adding 1 μM FCCP, a 
protonophore that dissipates the proton gradient across the inner mitochondrial membrane. Data 
were normalized by the value of control of each experiment. One-way ANOVA shows a 
significant main effect of As treatment on MRC: F (3, 73) = 65.16, P < 0.0001. Post hoc by 
Tukey’s multiple comparisons test shows that MRC was increased significantly in the group 
treated with 2 µM As, 5 µM As and 10 µM As compared to control group (*p<0.05). Results 




3.4 Arsenite Modulated Mitochondrial SOD in RBE4 cells 
Manganese superoxide dismutase (MnSOD), also known as superoxide dismutase 2 
(SOD2), is a primary mitochondrial antioxidant that neutralizes mitochondrial ROS through 
the conversion of superoxide to H2O2, and ultimately to H2O by catalase [88].  
As cellular antioxidant response appeared to directly correlate with mitochondrial 
dysfunction and mitochondrial oxidative stress, we next tested if 24 hrs of arsenite exposure 
in RBE4 cells changed MnSOD expression. Interestingly, we found that MnSOD 
expression significantly increased 35% after 2 µM arsenite exposure, while 5 µM and 10 
µM arsenite increased MnSOD expression by 20% and 25% compared with vehicle 
treatment, respectively (Figure 3.4). Taken together, this result indicates that the effect of 








Figure 3.4 Arsenite affect MnSOD expression in RBE4 cells. RBE4 were treated 
with 0-10 μM arsenite for 24 hrs. Cell lysate was analyzed by immunoblotting for MnSOD 
formation. A) Changes in protein level of MnSOD. B) Densitometry analysis representing 
the relative MnSOD change in protein level in treated cells compared to controls. Data were 
normalized by the value of control. One-way ANOVA shows a significant main effect of As 
treatment on MnSOD expression: F (2, 6) = 11.38, P=0.009. Post hoc by Tukey’s multiple 
comparisons test shows that MnSOD expression was increased significantly in the group 





3.5 Arsenite Induced Mitochondrial ROS Production in RBE4 Cells 
As mentioned above, arsenite can induce cellular ROS generation. Results presented in 
Figure 3.3 and Figure 3.4 suggested that arsenite exposure also resulted in mtBE loss and 
changes in mitochondrial antioxidant enzyme expression. To determine whether arsenite 
induces mitochondrial oxidative stress in RBE4 cells, we used live cell imaging of 
MitoSOX oxidation to detect ROS generation in mitochondria in our cell model. We found 
that 10 µM arsenite significantly promoted mitochondrial superoxide production in RBE4 
cells (Figure 3.5). Overall, these results suggest that mitochondria play an important role in 























Figure 3.5 Arsenite increased mitochondrial ROS production in a dose dependent 
manner in RBE4 cells. After treated with 5 or 10 μM of sodium arsenite for 24 hrs, RBE4 
cells were incubated with MitoSOX and Hoechst 33342 to label mitochondrial superoxide 
radical (red) and nuclei (blue), respectively. A) Arsenite increased mitochondrial ROS 
production in a dose dependent manner. Scale bar, 20 µm; objective, 40X B) Quantification 
of MitoSOX staining intensity. The mean fluorescence intensity per image was calculated 
and averaged over the three images, using Image J software. Data were normalized by the 
value of control of each experiment. One-way ANOVA shows a significant main effect of 
As treatment on MitoSOX intensity: F (2, 6) = 5.92, P=0.038; Post hoc by Tukey’s multiple 
comparisons test shows that MitoSOX intensity was increased significantly in the group 
treated with 10 µM As compared to control group (*p<0.05). Results were presented as 




3.6 Antioxidant Decreased Arsenite-Induced Mitochondrial ROS Production 
As shown in our previous experiments, arsenite exposure increased cellular ROS 
production as well as mitochondrial oxidative stress in RBE4 cells. Therefore, arsenic might 
induce toxicity in RBE4 cells via oxidative stress. To determine whether antioxidants rescue 
RBE4 cells from arsenic-induced mitochondrial oxidative stress, we treated RBE4 cells 
with 10 µM arsenite in the presence of the antioxidant NAC (2 mM) and superoxide anion 
radical scavenger tempol  (500 µM). As Figure 3.6 shows, NAC and tempol significantly 































Figure 3.6 Antioxidant decreased Arsenite-induced mitochondrial ROS 
production. RBE4 cells were treated with 10 μM of sodium arsenite in the absence or the 
presence of NAC or tempol for 24 hrs. Cells were incubated with MitoSOX for 20 minutes 
and Hoechst 33342 to label mitochondrial superoxide radical (red) and nuclei (blue) 
respectively. A) Both NAC and tempol treatment decreased arsenite induced mitochondrial 
ROS production in RBE4 cells. B) Quantification of MitoSOX staining intensity. Data were 
normalized by the value of control of each experiment. Results are mean ± SEM. One-way 
ANOVA shows a significant main effect of different treatment on MitoSOX intensity: F (3, 
12) = 5.70, P=0.011; Post hoc by Tukey’s multiple comparisons test shows that MitoSOX 
intensity was increased significantly in the group treated with 10 µM As compared to 
control group (*p<0.05) and MitoSOX intensity was decreased significantly in the group 
treated with NAC and the group treated with tempol compared to As treatment group (# 




3.7 Antioxidant Effects on Arsenite-Induced mtBE Loss in RBE4 Cells 
Next, we investigated the effect of NAC and tempol on mitochondrial function under 
arsenic exposure. The cells were prepared for analysis of mtBE by Seahorse XF96 Analyzer 
as described in the Methods. As shown in Figure 3.7, NAC treatment can rescue the 
arsenic-induced decrease in mitochondrial maximal oxygen consumption, which suggests 
that that it can block arsenic induce mitochondrial ETC impairment in RBE4. Surprisingly, 
another antioxidant compound, tempol had no significant effect on arsenic-induced 
impairment of maximal mitochondrial respiration compared with arsenite treatment alone. 
Considering the different ROS targets of these two antioxidant compounds, besides 
superoxide, other oxidative stress species, such as NO derived from  eNOS may also be 






Figure 3.7 Antioxidant compound effects on arsenite-induced mtBE loss in RBE4 
cells. Oxygen consumption of RBE4 cells after 24 hrs exposure to 10 µM sodium arsenite 
in the absence or presence of NAC or Tempol. OCR was manipulated with injections of 
oligomycin (20 μg/ml), FCCP (2 μM), and rotenone plus antimycin-A (1 μM). A) Represent 
bioenergetics profile of RBE4 cells treated with 10 µM arsenite and antioxidant compound. 
B) Maximal respiratory capacity (MRC) was achieved by adding 1 μM FCCP, a 
protonophore that dissipates the proton gradient across the inner mitochondrial membrane. 
Data were normalized by the value of control of each experiment. One-way ANOVA shows 
a significant main effect of different treatment on MRC: F (3, 80) = 81.28, P<0.0001. Post 
hoc by Tukey’s multiple comparisons test shows that MRC was decreased significantly in 
the group treated with As and the group treated with As + Tempol compared to control 





3.8 Antioxidant Effects on Arsenite-Induced RBE4 Monolayer Permeability 
Our previous findings have suggested that NAC can rescue arsenic-induced 
mitochondrial bioenergetics loss. Consistently, we found that NAC attenuated arsenite 
induced RBE4 monolayer permeability. In addition, another antioxidant compound tempol 
was unable to rescue arsenite induced RBE4 monolayer permeability (Figure 3.8), which is 






Figure 3.8 Antioxidant effects on arsenite-induced RBE4 monolayer permeability. 
RBE4 cells in culture inserts were grown to monolayer and exposed to arsenite (10 μM) 
with or without NAC (2 mM) or tempol (500 µM) for 6 days. The fluorescence of FITC-
dextran leaked from insert to plate well was assessed to determine the permeability. Data 
were normalized by the value of control (0 μM arsenite) of same day. Results were 
presented as mean ± SEM. One-way ANOVA shows a significant main effect of different 
treatment on FITC-dextran passage: F (3, 32) = 13.64, P= 0.00043. Post hoc by Tukey’s 
multiple comparisons test shows that FITC-dextran passage was increased significantly in 
the group treated with 10 µM As and treated with As + Tempol compared to control group 
(*p<0.05) and FITC-dextran passage was decreased significantly in the group treated with 




3.9 Arsenite Increased Autophagic Activity in RBE4 Cells  
As mentioned in the introduction, autophagy is active in endothelial cells in vitro and 
in vivo. Recently, autophagy has been reported to be necessary for regulating endothelial 
function, either protectively or detrimentally [4, 89, 90]. Thus, it is interesting and important 
to explore whether autophagy may be involved in RBE4 function under arsenite exposure. 
To explore whether arsenic alters autophagic activity in endothelial cells, we 
determined expression of autophagy markers in arsenic-treated RBE4 cells. Since the 
amount of LC3-II is clearly correlated with the number of autophagosomes, our approach 
was to detect LC3 conversion (LC3-I to LC3-II) in RBE4 by immunoblotting after 24 hrs 
treatment with various concentration of sodium arsenite. However, LC3-II itself is degraded 
by autophagy, making interpretation of the results of LC3 immunoblotting problematic. 
Since the amount of LC3 at a certain time point does not indicate autophagic flux, it is 
important to measure the amount of LC3-II delivered to lysosomes by comparing LC3-II 
levels in the presence and absence of lysosomal protease inhibitors. Therefore, in our 
experiment, a lysosomal inhibitor (20 mM NH4Cl) was added 4 hrs prior to cell harvest to 
inhibit lysosome degradation. Another problem with this method is that LC3-II tends to be 
much more sensitive to be detected by immunoblotting than LC3-I. [91]. Accordingly, we 
compare the ratio of LC3-II to LC3-1 as well as the formation of LC3-II.  
As shown in Figure 3.9, a significant increase of LC3-II was determined in RBE4 cells 
in the presence of lysosomal inhibitor NH4Cl. In addition, both the formation of LC3-II and 




absence and presence of NH4Cl. Therefore, these data indicated that the increased LC3-II 
expression and LC3-II/LC3-I ratio is induced by the arsenite increased autophagic activity 









Figure 3.9 Arsenite increased autophagic activity in RBE4 cells.  RBE4 cells were 
exposed to 0-10 μM arsenite for 24 hrs. Lysosomal inhibitor (20 mM NH4Cl) was added 4 
hrs prior to cell harvest to inhibit lysosome degradation. Cell lysates were analyzed by 
immunoblotting for LC3-B formation. NT: no treatment  
A) Immunoblotting of LC3-I and LC3-II.  
B) Quantification LC3-II band density in arsenite treated cells compared to controls. 
Two-way ANOVA shows a significant main effect of As treatment on LC3-II: F (3, 16) 
=13.32, P<0.0001. Two-way ANOVA also shows a significant main effect of NH4Cl 
treatment: F (1, 16) =24.61, P<0.0001. Interaction between As treatment and NH4Cl 
treatment F (3, 16) =2.92, p=0.066. Post hoc by Tukey’s multiple comparisons test shows 
that LC3-II/I was increased significantly in the group treated with 10 µM As with NT 
compared to control with NT (*p<0.05) and in the 2 µM and 10 µM As treatment with 
NH4Cl groups compared to control with NH4Cl(#p<0.05).  
C) Quantification LC3-II /LC3-I band density normalize to β-actin in arsenite treated 
cells compared to controls. Two-way ANOVA shows a significant main effect of As 
treatment on LC3-II/LC3-I: F (3, 16) =11.51, P=0.0003. Two-way ANOVA also shows a 
significant main effect of NH4Cl treatment: F (1, 16) =21.31, P=0.0002. Interaction between 
As treatment and NH4Cl treatment F (3, 14) =0.52, p=0.6685. Post hoc by Tukey’s multiple 
comparisons test shows that LC3-II/I was increased significantly in the group treated with 
10 µM As with NT compared to control with NT group(*p<0.05) and in the 2µM, 5µM and 
10 µM As treatment with NH4Cl groups compared to control with NH4Cl(#p<0.05).  
 Data were normalized by the value of control without NH4Cl treatment.  Results were 




3.10 Arsenite Increased Autophagic Activity in RBE4 cells by Oxidative Stress 
Our previous results indicated that arsenic induced ROS generation in RBE4 cells. 
Further, many studies suggested that the presence of ROS can trigger autophagy in many 
systems [72]. To determine whether arsenite induced oxidative stress is involved in the 
increased autophagic activity, we treated RBE4 cells with 10 µM sodium arsenite in the 
presence of antioxidant NAC (2 mM) and tempol (500 µM). As shown in Figure 3.10, both 
NAC and tempol can efficiently block arsenite induced increased LC3-II expression as well 
as LC3-II/LC3-I ratio in the presence or absence of NH4Cl, which suggest that arsenite 









Figure 3.10 Arsenite increased autophagic activity in RBE4 cells by oxidative 
stress. A) RBE4 cells were treated with 10 μM arsenite in the presence of NAC (2 mM) and 
tempol (500 µM) for 24 hrs. Lysosomal inhibitor (20 mM NH4Cl) was added 4 hrs prior to 
cell harvest to inhibit lysosome degradation. Cell lysate was analyzed by immunoblotting 
for LC3-B formation. NT: no treatment A) Immunoblotting of LC3-I and LC3-II.  
B) Quantification LC3-II band density normalized to β-actom in arsenite treated cells 
compared to controls. Two-way ANOVA shows a significant main effect of As treatment 
on LC3-II: F (3, 16) =9.04, P=0.001. Two-way ANOVA also shows a significant main 
effect of NH4Cl treatment: F (1, 16) =20.80, P=0.0003. Interaction between As treatment 
and NH4Cl treatment F (3, 16) =1.05, P=0.398.  Post hoc by Tukey’s multiple comparisons 
test shows that LC3-II was increased significantly in the group treated with 10 µM As with 
NT compared to control with NT group (*p<0.05) and in the 10 µM As with NH4Cl 
treatment group compared to control with NH4Cl treatment(#p<0.05).  
C) Quantification LC3-II/LC3-I band density in arsenite treated cells compared to 
controls. Two-way ANOVA shows a significant main effect of As treatment on LC3-
II/LC3-I: F (3, 16) =7.73, P=0.0021. Two-way ANOVA also shows a significant main 
effect of NH4Cl treatment: F (1, 16) =23.50, P=0.0002. Interaction between As treatment 
and NH4Cl treatment: F (3, 16) =0.24, P=0.867. Post hoc by Tukey’s multiple comparisons 
test shows that LC3-II was increased significantly in the group treated with 10 µM As with 
NT compared to control with NT group (*p<0.05) and in the 10 µM As with NH4Cl 
treatment group compared to control with NH4Cl treatment(#p<0.05).  
Data were normalized by the value of control without NH4Cl treatment. Results were 




3.11 3-MA Effects on Arsenite-Induced RBE4 Monolayer Permeability 
To investigate whether the increased autophagic activity is involved in arsenite- 
induced increased RBE4 permeability, we used autophagy inhibition approach to test this 
hypothesis 
3-MA is a commonly used autophagy inhibitor and it inhibits autophagy by blocking 
autophagosome formation via the inhibition of type III phosphatidylinositol 3-kinases (PI-
3K).  Therefore, we treated RBE4 cell with 10 µM arsenite in the absence or presence of 3-
MA and then determined the RBE4 monolayer permeability using the paracellular 
permeability method. 
First, we tested 3-MA (0-10 µM) effect on autophagic activity. As shown in Figure 
3.10 A , 5 mM and 10 mM significantly decreased arsenite-induced LC3-II expression, In 
addition, 3-MA has been reported typically used at a concentration of 5 mM as an 
autophagy inhibitor [92]. Therefore, we use 3-MA at a concentration of 5 mM in our 
paracellular permeability study. Surprisingly, we found that 5 mM 3-MA treatment was 
unable to attenuate the arsenite-induced increased in monolayer permeability in RBE4 cells 






Figure 3.11 3-MA effects on arsenite-induced RBE4 monolayer permeability. A) 
RBE4 cells were exposure to 10 μM arsenite in the presence of autophagy inhibitor 3-MA 
(0-10 μM) for 24 hrs. Cell lysate was analyzed by immunoblotting for LC3-B formation. B) 
RBE4 cells in culture inserts were grown to monolayer and exposed to arsenite (10 μM) 
with or without 3-MA (5 mM) for 1,3, and 6 days. The fluorescence of FITC-dextran leaked 
from insert to plate well was assessed to determine the permeability. Data were normalized 
by the value of control (0 μM arsenite) of same day. One-way ANOVA shows a significant 
main effect of different treatment on FITC-dextran passage: F (2, 24) = 20.82, P<0.0001. 
Post hoc by Tukey’s multiple comparisons test shows that FITC-dextran passage was 
increased significantly in the group treated with 10 µM As and treated with As + 3-MA 





3.12 3-MA effects on arsenite-increased Mitochondrial SOD expression 
To investigate the effect of autophagy inhibitors on the mitochondria antioxidant 
system, we determined the effects of 3-MA on arsenite increased MnSOD expression in 
RBE4 cells. 
Our previous results suggested that 2 µM arsenite significantly increased MnSOD 
expression in RBE4 cells. Therefore, we treated RBE4 cells with 2 µM arsenite in the 
presence of 5 mM 3-MA to study autophagy inhibitor effects on MnSOD expression. We 
found that 3-MA treatment further increased arsenite-induced MnSOD overexpression in 






Figure 3.12 3-MA effects on arsenite-increased Mitochondrial SOD expression. 
RBE4 cells were treated with 10 μM arsenite in the absence of presence of 5 mM 3-MA for 
24 hrs. Cell lysate was analyzed by immunoblotting for MnSOD formation. A) Changes in 
protein level of MnSOD. B) Densitometry analysis representing the relative change in 
protein level in treated cells compared to controls. Data were normalized by the value of 
control. One-way ANOVA shows a significant main effect of As treatment on MnSOD 
expression: F (2, 6) = 20.18, P=0.002. Post hoc by Tukey’s multiple comparisons test shows 
that MnSOD expression was increased significantly in the group treated with 2 µM As 
compared with control(*p<0.05) and in the group treated with As + 3-MA compared with 




3.13 3-MA effects on arsentie-induced mtBE loss in RBE4 cells 
To determine whether 3-MA has effects on arsenite- induced mtBE loss in RBE4 cells, 
we treated RBE4 cells with 10 µM arsenite in the absence or presence of 5 µM 3-MA. The 
cells were then prepared for analysis of mtBE by Seahorse XF96 Analyzer as described in 
the Methods. Considering 3-MA may have effects on RBE4 cell viability, we further 
normalized RBE4 cells oxygen consumption by protein concentration using BCA assay. 
As shown in Figure 3.12, we found that 5mM 3-MA significantly increased the MRC 
of RBE4 under normal condition. However, 5 mM 3-MA had no effect on the MRC of 






Figure 3.13 3-MA effects on arsenite-induced mtBE loss in RBE4 cells. Oxygen 
consumption of RBE4 cells were determined after 24 hrs exposure of 10 µM sodium 
arsenite in the absence or presence of 5 mM 3-MA. OCR was manipulated with injections 
of oligomycin (20 μg/ml), FCCP (2 μM), and rotenone plus antimycin-A (1 μM). A) 
Represent bioenergetics profile of RBE4 cells treated with arsenite and antioxidant 
compound. B) Quantification of MRC. Data were normalized by the value of control of 
each experiment. One-way ANOVA shows a significant main effect of different treatment 
on MRC: F (3, 24) = 55.38, P<0.0001. Post hoc by Tukey’s multiple comparisons test 
shows that MRC was increased significantly in the group treated with 3-MA compared to 
control group and was decreased significantly in the group treated with As and As + 3-MA 
compared to the control group (*p<0.05). Results were presented as mean ± SEM. n=6-8 




Chapter 4 Discussion 
Arsenic is a major health concern globally, with over 100 million people exposed to 
unhealthy levels of inorganic arsenic through contaminated drinking water. Recently, 
arsenic exposure was reported to cause CNS alterations, including learning, memory, and 
concentration deficits [93]. Despite these widely reported neurotoxic effects, the cellular 
and molecular mechanisms of arsenic on the CNS are not well understood. As brain 
endothelial cells play important roles in maintaining the functional integrity of brain tissue 
under toxic exposure, we focused on alterations in cerebral endothelial cells after arsenic 
treatment to study the mechanism of arsenic toxicity in our study. 
Vascular permeability is considered as an important indicator of BECs function. In fact, 
it is regulated, in part, through changes in paracellular permeability which refers to the 
movement of substances across the endothelial barrier via the intercellular space between 
adjacent endothelial cells [94]. Therefore, we focused on arsenite’s effects on RBE4 
paracellular permeability to study arsenic toxicity in endothelial cells in our experiments. 
Using a 40-kDa molecular weight tracer, we found a dose and time dependent increase 
in FITC-dextran permeability RBE4cells. . This result indicates that arsenite treatment 
increased paracellular permeability in RBE4 cells. More importantly, our findings from 
RBE4 cells are consistent with what we observed previously with b.End3 cells. Similar to 
the results in RBE4, we found arsenite increased paracellular permeability and we further 
reported non-uniform disruption of VE-cadherin or ZO-1 and increased gap formation 




In our experiments, we studied arsenic toxicity using an in vitro model of BBB 
consisting of brain endothelial cells. However, it should be acknowledged that the BBB is 
formed of several cell types, such as endothelial cells, astrocytes, perivascular microglia, 
pericytes and neurons, and their interactions determine the BBB function [95]. Therefore, 
we should note that the results presented in our current study have some limitations. 
However, it provides proof of principle that arsenic toxicity may increase BBB permeability 
in the on CNS and supports for future studies with animal models. 
Studying the mechanisms of toxicity by inorganic arsenic species is a complex task, as 
arsenic interacts with a large number of targets to disrupt a large number of cellular 
processes. Among them, ROS have been reported to play an important role in arsenic 
toxicity both in carcinogenic or non-carcinogenic studies [96, 97]. Therefore, further studies 
of the sources of ROS and how they are produced is a worthwhile effort in investigating 
mechanisms of arsenic toxicity. Previously, our laboratory has reported that NADPH 
oxidase may not be an important player in arsenite-induced ROS production in brain 
endothelial cells. We found arsenic did not significantly increase NADPH oxidase activity 
in bEnd3 until its concentration reached 20 µM and the NADPH oxidase inhibitor, DPI did 
not rescue changes in barrier function of bEnd3 cells that were exposed to 10 µM arsenite 
for 6 days [3]. Besides NADPH oxidase, mitochondria are also well recognized as main 
sources of arsenic-induced ROS generation and impaired mitochondrial function has been 
found upon arsenic exposure in many in vitro and in vivo models [31, 98]. Accordingly, we 





Our current study further confirmed arsenic induced ROS production in BECs using 
CMH spin trap with EPR spectroscopy. We found an increasing free radical signal in RBE4 
cells with increased arsenic concentration, which indicated that arsenic-induced ROS 
generation occurs in a concentration dependent manner. More importantly, we found that 
sodium arsenite dose-dependently increased mitochondrial superoxide and altered MnSOD 
expression in RBE4 cells. In addition, arsenic exposure also resulted in decreased mtBE in 
RBE4 cells. Therefore, we concluded that mitochondria were important targets for the 
arsenic toxicity and arsenic may induce oxidative stress via mitochondrial ROS generation 
in BECs. 
To further confirm the role of oxidative stress in arsenic toxicity in BECs, we treated 
RBE4 cells in the presence of two antioxidant compounds: NAC and tempol. We found that 
both NAC and tempol rescued arsenite-induce mitochondrial superoxide production as 
determined by MitoSOX staining. In addition, NAC also rescued the arsenic-induced 
decreased mtBE and increased monolayer permeability in RBE4 cells. However, another 
antioxidant tempol had no significant effect on arsenic-decreased in mtBE and increased 
permeability in RBE4 cells. Taken together, these data suggest that arsenite-induced ROS in 
RBE4 cells is mainly generated from mitochondria, and the increased ROS causes further 
damage to mitochondria to inhibit their function. In turn, these malfunctioning mitochondria 
can produce more ROS leading to sustained ROS accumulation. The arsenic-increased ROS 
generation is responsible for increased monolayer permeability in RBE4 cells. 
In our experiments, we identified mitochondrial ROS generation as an important 




ROS production outside mitochondria, especially since tempol could not block arsenic-
induced permeability in RBE4 cells, which suggests O2•– is not the only ROS species 
induced by arsenic. Our previous result has suggested that NADPH oxidase may not be 
involved in arsenic-induced oxidative stress in BECs [78]. Besides NADPH oxidase and 
mitochondria, other sources of ROS production that are induced by arsenic have been 
recognized. It has been suggested that arsenic may induce oxidative stress by cycling 
oxidative states such as Fe, or by interacting with antioxidant and increasing inflammation, 
resulting in the accumulation of ROS in cells. Therefore, more research needs to be done to 
investigate the source of ROS in BECs under arsenic exposure. 
Another important finding of our study is that the general antioxidant NAC rescued 
arsenic-induced toxicity including the decreased mtBE as well as the increased endothelial 
cell permeability in RBE4 cells; we did not observe this effect with the superoxide 
scavenger tempol. It is generally assumed that the action of NAC results from its 
antioxidative or free radical scavenging property as an antioxidant through increasing 
intracellular GSH levels [99]. In contrast, tempol mainly promotes metabolism of O2•− at 
rates that are similar to SOD. Therefore, we propose that arsenite induced-toxicity in RBE4 
may not occur only via generation O2•−, but also through other oxidative stress species as 
well, such as H2O2. In addition, another possible explanation is that tempol may have toxic 
effects in RBE4 cells. As mentioned in the Background, tempol is a cell membrane-
permeable amphilite nitroxide and improves NO bioavailability in vitro and in vivo. NO 
inhibits the mitochondrial cytochrome c oxidase (complex IV) in competition with oxygen 




further confirm whether NAC can be a therapeutic approach for arsenic-induced toxicity in 
BECs, more in vivo studies need to be done. 
An interesting link between ROS production and arsenic toxicity in endothelial cells 
might be autophagy. Autophagy is a highly conserved process in eukaryotes in which the 
cytoplasm, including excess or aberrant organelles, is sequestered into double-membrane 
vesicles and delivered to the degradative organelle, the lysosome/vacuole, for breakdown 
and eventual recycling. This process has an important role in various biological events such 
as adaptation to changing environmental conditions, cellular remodeling during 
development and differentiation, and determination of lifespan [101]. Although autophagy 
may also mediate protective effects against some diseases, many studies have shown that 
autophagy is involved in many pathological conditions. In recent years, research on the 
autophagy has greatly increased. An advanced understanding of the importance of 
autophagy in vascular physiology led us to investigate the correlation of autophagy with 
endothelial barrier dysfunction [102]. Autophagy induction has been reported to increase 
angiogenesis in BAECs [103]. In addition, Western blot results have shown that the mTOR 
inhibitor rapamycin induced autophagy, which is indicated by the increased level of 
autophagy markers LC3 and beclin-1, [104]. Meanwhile, autophagy has been reported to 
mediate the degradation of the junction protein ZO-1 and VE-cadherin in HMEC-1 cells, 
resulting in an increase in vascular permeability [76]. Therefore, we determined whether 
autophagy is involved in arsenic toxicity in RBE4 cells. 
 In our present experiment, 24 hrs arsenic treatment increased the expression of LC3-II 




These results demonstrated that the increased level of autophagy markers in RBE4 cells is 
due to arsenic increased autophagic activity not a compromised lysosome activity. In 
addition, we found both NAC and tempol rescued arsenic-induced increased expression of 
LC3-II as well as LC3-II/LC3-I ratio in RBE4 cells. Taken together, our study indicated 
arsenic-induced autophagy by ROS generation in RBE4 cells. 
To investigate the role of autophagy in arsenic toxicity in RBE4, we treated RBE4 
cells with arsenite in the presence of 3-MA, which has been widely used as an autophagy 
inhibitor based on its inhibitory effect on class III PI3K activity. We found that 3-MA 
reduced the increase in LC3-II and LC3-II/LC3-I ratio in RBE4 cells induced by arsenate 
treatment. However, 3-MA didn’t rescue the arsenic-induced increase in permeability. In 
addition, although 3-MA further increased the MRC in RBE4 under control condition, it did 
not rescue the arsenic-induced decline in mtBE. One of the important problems using 3-MA 
is that it may have dual roles in modulating autophagy via different temporal patterns via 
inhibition of class I and III phosphoinositide 3-kinases. Recently, an increased level of 
autophagy has been found in cells treated with 3-MA for a prolonged period [66]. In our 
experiment, we only confirmed that 3-MA reduced arsenic-induced autophagy after 24 hrs 
treatment. However, we treated RBE4 cells with 3-MA and arsenite for 6 days to perform 
paracellular permeability assays in RBE4 cells. Since the major limitation of the RBE4 
models is the relatively high paracellular permeability to small molecules, the RBE4 model 
may be unable to show us the effect of autophagy inhibitor on arsenic-induced permeability. 
Therefore, more experimental approaches and more autophagy inhibitors should be used to 




investigated the effect of 3-MA on BECs permeability by using paracellular permeability 
assay in RBE4 cells, which is limited to studying the endothelial permeability of small 
molecules.  Thus, it will be worthwhile to study if 3-MA has effects on RBE4 TJs and AJs 
protein such as ZO-1 and VE-cadherin. In addition, during the study of autophagy 
mechanisms, other autophagy inhibitors besides 3-MA have been used in many studies. For 
example, Lys 05, which accumulates within and deacidifies the lysosome, resulted in 
impaired autophagy and tumor growth in many studies [105]. Interestingly, as a new 
lysosomal autophagy inhibitor, Lys05 has a better therapeutic index and has the potential 
advantage to be developed further into a drug for autophagy-targeting therapy [106]. 
In addition, the relationship between autophagy and vascular permeability factors is 
also worthwhile to study. Vascular endothelial growth factor (VEGF) is a key regulator of 
vascular permeability [107]. Detailed analysis of the published literature has shown that in 
vivo and in vitro VEGF-mediated permeability has common involvement of many specific 
signaling pathways, in particular of junctional signaling proteins such as vascular 
endothelial cadherin and the tight junctional proteins zona occludens and occludin linked to 
the actin cytoskeleton [108]. Research in our laboratory previously reported VEGF antibody 
reversed VE-cadherin and ZO-1 disruption induced by arsenite, which suggests that up-
regulated VEGF may play an important role in the arsenite-induced permeability increases 
in ECs [3]. Recently, the relationship between the role of VEGF and autophagy has been 
reported [109]. Autophagy was reported to drive the secretion of VEGF in mesenchymal 
stem cells (MSC) [110]. In addition, inhibiting autophagy could impair VEGF-induced 




important to study the relationship between autophagy and VEGF overexpression in arsenic 
treated ECs. 
In summary, our present results provide a potential mechanism by which arsenic 
induces toxicity in brain endothelial cells (Figure 4.1). We have identified that arsenic-
induced mitochondrial dysfunction might be an important source of ROS generation, and 
the increased ROS may cause further damage to mitochondria and inhibit their function. In 
turn, these malfunctioning mitochondria can produce more ROS causing a loop of 
increasing ROS. We also found that arsenic-increased ROS generation plays an important 
role in arsenic-induced endothelial permeability in BECs by using antioxidant treatment. 
We have further identified NAC was an efficient treatment for arsenic-induced increased 
permeability and mtBE loss in RBE4 cells. In addition, we also found that arsenic-induced 
autophagy via ROS generation and it may be involved in arsenic toxicity in endothelial cells. 
However, the role of autophagy in BECs permeability is still unclear and more research 
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